Table 3. Patient (at the time of transplant) and donor characteristics.
| Variable | White | Black | Hispanic | Asian | Others |
|---|---|---|---|---|---|
| (N = 63581) | (N = 7847) | (N = 11758) | (N = 3912) | (N = 1035) | |
| Recipients’ characteristics at transplantation: | |||||
| Age, Mean (SD) | 54.8 (10.2) | 51.6 (12.2) | 53.8 (10.5) | 55.2 (10.9) | 52.2 (11.0) |
| Recipient gender: Female | 20226 (32%) | 3282 (42%) | 4186 (36%) | 1269 (32%) | 423 (41%) |
| Recipient BMI, Mean (SD) | 28.6 (5.7) | 28.5 (6.2) | 28.9 (5.6) | 25.0 (4.4) | 29.7 (6.0) |
| Morbidly Obese | 2466 (4%) | 378 (5%) | 518 (4%) | 21 (1%) | 68 (7%) |
| Albumin, Mean (SD) | 3.1 (0.7) | 2.9 (0.8) | 3.0 (0.8) | 3.3 (0.8) | 3.0 (0.7) |
| Bilirubin (mg/dL), Mean (SD) | 8.0 (10.5) | 10.0 (11.6) | 10.2 (12.5) | 8.7 (12.5) | 10.1 (12.3) |
| Serum Creatinine, Mean (SD) | 1.4 (1.03) | 1.5 (1.20) | 1.4 (1.10) | 1.2 (0.95) | 1.4 (0.97) |
| INR, Mean (SD) | 1.9 (1.3) | 2.1 (2.1) | 2.0 (1.3) | 1.8 (1.5) | 2.1 (1.2) |
| MELD score, Mean (SD) | 21.3 (10.2) | 22.9 (11.2) | 23.2 (11.4) | 18.9 (12.2) | 23.4 (11.2) |
| Ascites is moderate at transplant | 16883 (27%) | 1754 (22%) | 3256 (28%) | 633 (16%) | 291 (28%) |
| Encephalopathy is 3–4 at transplant | 6593 (10%) | 921 (12%) | 1304 (11%) | 364 (9%) | 156 (15%) |
| KPS categories at transplant | |||||
| 10–40 | 17497 (28%) | 2442 (31%) | 4038 (34%) | 953 (24%) | 354 (34%) |
| 50–70 | 22145 (35%) | 2543 (32%) | 3959 (34%) | 1156 (30%) | 361 (35%) |
| 80–100 | 14712 (23%) | 1767 (23%) | 2201 (19%) | 1250 (32%) | 228 (22%) |
| Missing | 9227 (15%) | 1095 (14%) | 1560 (13%) | 553 (14%) | 92 (9%) |
| Child-Pugh categories at transplant | |||||
| A:5 or 6 points | 6664 (12%) | 1003 (14%) | 1165 (11%) | 1177 (33%) | 115 (12%) |
| B:7–9 points | 17372 (30%) | 1765 (24%) | 2846 (27%) | 908 (25%) | 215 (22%) |
| C:>9 points | 33780 (58%) | 4449 (62%) | 6705 (63%) | 1481 (42%) | 655 (66%) |
| Medical condition | |||||
| In intensive care unit | 6495 (11%) | 1107 (15%) | 1816 (17%) | 557 (16%) | 154 (16%) |
| Hospitalized not in ICU | 9866 (17%) | 1327 (18%) | 2207 (21%) | 465 (13%) | 190 (19%) |
| Not hospitalized | 41448 (72%) | 4783 (66%) | 6685 (62%) | 2545 (71%) | 639 (65%) |
| Donors’ characteristics: | |||||
| Donor age (years), Mean (SD) | 41.9 (16.6) | 40.4 (16.1) | 41.3 (16.8) | 41.1 (17.7) | 40.7 (16.7) |
| Donor gender: Female | 23177 (40%) | 3035 (42%) | 4457 (42%) | 1623 (45%) | 424 (43%) |
| Creatinine, Mean (SD) | 1.6 (1.70) | 1.6 (1.74) | 1.6 (1.73) | 1.6 (1.73) | 1.6 (1.81) |
| Bilirubin, Mean (SD) | 0.9 (1.04) | 0.9 (1.39) | 1.0 (1.48) | 0.9 (1.16) | 0.9 (1.45) |
| Donor Diabetes | 6311 (11%) | 808 (11%) | 1182 (11%) | 372 (11%) | 97 (10%) |
| Calculated Donor BMI, Mean (SD) | 27.6 (6.3) | 27.3 (6.2) | 27.0 (5.9) | 26.0 (5.6) | 27.4 (6.4) |
| DRI, Mean (SD) | 1.8 (0.45) | 1.8 (0.42) | 1.8 (0.45) | 1.9 (0.46) | 1.8 (0.45) |
BMI—body mass index; DRI—donor risk index; KPS—Karnofsky Performance Status; MELD—model for end-stage liver disease; SD–standard deviation.